<HTML><HEAD><TITLE>Investors</TITLE>
<META http-equiv=Content-Language content=en-us>
<META http-equiv=Content-Type content="text/html; charset=windows-1252">
<META content="MSHTML 6.00.2600.0" name=GENERATOR>
<META content=FrontPage.Editor.Document name=ProgId></HEAD>
<BODY>
<DIV align=center>
<CENTER>
<TABLE borderColor=#89be65 height=1 cellSpacing=0 borderColorDark=#000000
cellPadding=7 width="57%" borderColorLight=#000000 border=2>
<CAPTION></CAPTION>
<TBODY>
<TR>
<TD vAlign=top borderColor=#ffffff borderColorLight=#ffffff width="100%"
bgColor=#800000 borderColorDark=#ffffff height=43>
<P align=center><B><FONT face=Verdana color=#efefef size=5>Wall Street
Stockwatch<BR></FONT><FONT face=Verdana color=#ffa346 size=2>Wasatch
Pharmaceuticals: Company Update</FONT></B></P></TD></TR>
<TR>
<TD vAlign=top align=left width="100%" height=372>
<BLOCKQUOTE><BR><B><FONT face=Verdana size=5><I>Special Corporate
Update</I> </FONT><FONT face=Verdana color=#800000
size=3>WSCH</FONT></B><FONT size=2><BR></FONT>
<DIV align=center>
<TABLE borderColor=#efefef height=108 cellSpacing=0
borderColorDark=#efefef cellPadding=3 width="83%"
borderColorLight=#efefef border=1>
<TBODY>
<TR>
<TD borderColor=#800000 borderColorLight=#800000 width="35%"
bgColor=#800000 borderColorDark=#800000 height=32><FONT
face=Verdana color=#efefef size=2>Company
Name </FONT></TD>
<TD vAlign=top width="165%" bgColor=#efefef height=32><B><FONT
face=Verdana color=#800000 size=2>Wasatch
Pharmaceuticals</FONT><FONT face=Verdana color=#392b55 size=1>
</FONT><FONT color=#fb7d00><FONT face=Verdana
size=1>(O</FONT></FONT><FONT face=Verdana color=#fb7d00
size=1>TCBB: WSCH)</FONT></B></TD></TR>
<TR>
<TD borderColor=#800000 borderColorLight=#800000 width="35%"
bgColor=#800000 borderColorDark=#800000 height=16><FONT
face=Verdana color=#efefef size=2>Current Price</FONT></TD>
<TD vAlign=top width="165%" bgColor=#efefef height=16><FONT
face=Verdana color=#800000 size=2>$0.007</FONT></TD></TR>
<TR>
<TD borderColor=#800000 borderColorLight=#800000 width="35%"
bgColor=#800000 borderColorDark=#800000 height=32><FONT
face=Verdana color=#efefef size=2>52-Week High</FONT></TD>
<TD vAlign=top width="165%" bgColor=#efefef height=32><FONT
face=Verdana color=#800000 size=2>$1.95</FONT></TD></TR>
<TR>
<TD borderColor=#800000 borderColorLight=#800000 width="35%"
bgColor=#800000 borderColorDark=#800000 height=1><FONT
face=Verdana color=#efefef size=2>52-Week Low</FONT></TD>
<TD vAlign=top width="165%" bgColor=#efefef height=1><FONT
face=Verdana color=#800000
size=2>$0.0045</FONT></TD></TR></TBODY></TABLE></DIV>
<P><FONT face=Verdana size=2>News from Wasatch Pharmaceutical <B>(OTCBB:
WSCH) </B>is hard to come by lately. Gary Heesch, CEO of Wasatch,
doesn't buy the idea that a press release every day is productive.
He feels <B>"it is usually perceived as an effort to over- promote the
stock."</B> But what about the future of WSCH? Why should
anyone buy or hold their stock with no news?</FONT></P>
<P><FONT face=Verdana size=2><B>Mr. Heesch </B>feels that past news
releases and their record of Company accomplishments speak for
themselves. For example, Wasatch, now in its <B>18th year of
research</B>, has produced skin care products for the treatment of most
common skin disorders. This puts them <B><U>years ahead of the
competition.</U></B></FONT></P>
<P><FONT face=Verdana size=2>In the last 12 months, WSCH has addressed a
whole new dimension in preparation for <B>launching its products into
the worldwide marketplace</B>, so that millions of people will finally
have access to therapies that allow them to remedy their skin disorders
and live more normal lives. This preparation involved:<BR><BR><B>(1) A
new management team </B>with impressive individual records of creating
billions of dollars in revenue for Oracle, Bausch & Lomb, and Warner
Lambert.<BR><BR><B>(2) The establishment</B> of a new AISC Distribution
Center that is fully inventoried with products ready for
shipment.<BR><BR><B>(3) Establishing beautiful corporate offices
</B>separate from the company's clinic.<BR><BR><B>(4) Relocation </B>of
the American Institue of Skin Care clinic to a facility designed to be
the prototype for future clinics.<BR><BR>To cap off the last 12 months,
<B>patents were filed for five new products </B>that will be packaged
and ready for release to physicians and hospitals this year. All
of these accomplishments translate into a variety of activites and
relationships <B>that will insure the growth and stability of
WSCH.</B><BR><BR>When pressed to reveal this year's plans, Mr. Heesch
wants to <B>reserve the substance of these activities until they are
completed and tucked away.</B> He did say that existing activities
and plans include the <B>acquisition</B> of existing medical clinics,
ongoing discussion for<B> foreign licensing,</B> conversations with
groups of physicians that can represent as many as <B>2,000 physicians
converting their patients </B>to Wasatch products for their skin care
problems, and also a <B>possible merger </B>that will <U>expand</U>
WSCH's sphere of influence in the medical
community. <BR><BR><B>As these activities come to
fruition</B>, they will be disclosed to WSCH shareholders and the public
in detail. Unlike many companies struggling with today's economy,<B>
Wasatch Pharmaceutical is alive and well and working towards a
productive future.<BR><BR></B></FONT><B><FONT face=Verdana
size=3><I>Stay tuned for plenty more to come from
WSCH.</I></FONT></B></P></BLOCKQUOTE>
<CENTER></CENTER></TD></TR>
<CENTER>
<TR>
<TD vAlign=top width="100%" bgColor=#800000 height=368><FONT face=Verdana
color=#fb7d00 size=2><B>To be removed from future mailings, please respond
<BR>to this email with "Remove" in the subject line</B></FONT><FONT
face=Verdana color=#dddddd size=1><BR><BR></FONT><FONT color=#ffffff><FONT
face=Verdana size=1>DISCLAIMER: <BR>Information within this email
contains "forward looking statements" within the meaning of Section 27A of
the Securities Act of 1933 and Section 21B of the Securities Exchange Act
of 1934. Any statements that express or involve discussions with respect
to predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not statements of
historical fact and may be "forward looking statements."<BR><BR>Forward
looking statements are based on expectations, estimates and projections at
the time the statements are made that involve a number of risks and
uncertainties which could cause actual results or events to differ
materially from those presently anticipated. Forward looking statements in
this action may be identified through the use of words such as "projects",
"foresee", "expects", "will," "anticipates," "estimates,"
"believes," "understands" or that by statements indicating certain actions
"may," "could," or "might" occur. All information provided within
this email pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. Emerging Growth Stock
Alert advises all readers and subscribers to seek advice from a
registered professional securities representative before deciding to trade
in stocks featured within this email. None of the material within
this report shall be construed as any kind of investment advice.<BR><BR>In
compliance with the Securities Act of 1933, Section17(b), Emerging Growth
Stock Alert discloses the receipt of ten million unrestricted shares of
WSCH from a third party for the publication of this report and
additional<SPAN style="mso-spacerun: yes"> </SPAN>services related to
WSCH. Be aware of an inherent conflict of interest resulting from such
compensation due to our intent to profit from the sale of these
shares. All factual information in this report was gathered
from public sources, including but not limited to SEC filings, Company
Press Releases, and the company's website at wasatchpharm.com.<SPAN
style="mso-spacerun: yes"> </SPAN>Emerging Growth Stock Alert
believes this information to be reliable but can make no guarantee as to
its accuracy or completeness. Use of the material within this email
constitutes your acceptance of these terms.</FONT></FONT><FONT
face=Verdana color=#5f5f5f size=1><BR><BR></FONT><FONT face=Verdana
color=#fb7d00 size=2><B>To be removed from future mailings, please respond
<BR>to this email with "Remove" in the subject line</B></FONT> </TD></TR>
<TR>
<TD vAlign=top width="100%" bgColor=#800000 height=368>
</TD></TR></TBODY></center></TABLE><p> </p></CENTER></DIV>
<a href="http://rd1.hitbox.com/rd?acct=WQ520325IBVW57EN8" target=_top><img
src="http://hg1.hitbox.com/HG?hc=wf120&cd=1&ce=u&hb=WQ520325IBVW57EN8&n=PUT+PAGE+NAME+HERE&l=1"
border="0" width=1 height=1></a><div><font face="MS Sans Serif,Arial,Helvetica" size=1><a
href="http://counter.hitbox.com/a/hitboxfree.cgi" target="_blank"></a></font></div>
</BODY></HTML>